In particular, high-risk APS patients (triple aPL positivity plus vascular thrombosis and/or severe pregnancy complications/placental insufficiency) have higher endoglin+ EV, TF+ EV and platelet derived-EV in all three trimesters, sustaining a major vascular activation. This evidence concerns the gene TF and autoimmune polyendocrinopathy.